Screener
Aurinia Pharmaceuticals AUPH Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's total equity?
- Aurinia Pharmaceuticals (AUPH) reported total equity of $614.86M in Q2 2026.
- How has Aurinia Pharmaceuticals's total equity changed year-over-year?
- Aurinia Pharmaceuticals's total equity increased by 83.4% year-over-year, from $335.3M to $614.86M.
- What is the long-term trend for Aurinia Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total equity has grown at a 7.4% compound annual growth rate (CAGR), from $407.75M to $581.33M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Aurinia Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude